Hemogenyx Therapeutics is a biopharmaceutical company developing a new treatment for blood diseases, such as leukemia, lymphoma and bone marrow (“BMâ€) failure. The Company leverages a special class of cells that can generate cancer-free, patient-matched blood stem cells.
